vaayaa Inclusive Education
Micro-Diploma

HIV AIDS Management

5-Year Access Self-Paced Learning Certificate Included

Unlock Full Course

Get instant access to all sections and earn your verified certificate.

$9.99

Table of Contents

FREE PREVIEW — Section 1 of Module 1

History and Global Impact

Unit
  • Emergence: HIV was first identified in the early 1980s when unusual clusters of Pneumocystis pneumonia and Kaposi sarcoma were reported among previously healthy individuals in the United States. The syndrome was initially named GRID (Gay-Related Immune Deficiency) before the term AIDS was adopted in 1982.
  • Pandemic spread: By the late 1980s, HIV had spread to every continent, with sub-Saharan Africa bearing the heaviest burden. The virus likely crossed from chimpanzees to humans in Central Africa earlier in the 20th century through bushmeat hunting.
  • Global burden: As of 2023, approximately 38 million people live with HIV worldwide, with about 1.3 million new infections and 630,000 AIDS-related deaths annually. The epidemic has claimed over 40 million lives since its start.
  • Treatment revolution: The development of antiretroviral therapy (ART) in the mid-1990s transformed HIV from a fatal disease to a manageable chronic condition. Effective ART reduces viral load to undetectable levels, preventing transmission and preserving immune function.
  • UNAIDS 95-95-95 targets: Global goals aim for 95% of people living with HIV to know their status, 95% of diagnosed to receive ART, and 95% of those on ART to achieve viral suppression by 2025. Progress varies by region.
  • Economic impact: HIV/AIDS reduces labor productivity, increases healthcare costs, and orphans children. Countries with high prevalence face significant GDP losses and strain on health systems.
  • Stigma and discrimination: Social stigma remains a major barrier to testing and treatment. Many people hide their status due to fear of rejection, job loss, or violence, which undermines public health efforts.
  • Research milestones: Key advances include the discovery of HIV as the causative agent (1983), development of the first ELISA test (1985), and clinical trials showing ART efficacy (1996). Ongoing research focuses on vaccine development and cure strategies.
  • International response: The Global Fund, PEPFAR, and UNAIDS coordinate funding and policy. These programs have saved millions of lives but face sustainability challenges as donor funding plateaus.
  • Future outlook: With expanded access to prevention and treatment, the goal of ending AIDS as a public health threat by 2030 is achievable but requires sustained commitment and innovation in service delivery.
  • Prevention strategies: Comprehensive prevention includes condom use, pre exposure prophylaxis (PrEP) for high risk individuals, post exposure prophylaxis (PEP) within 72 hours of exposure, and harm reduction for people who inject drugs. Voluntary medical male circumcision reduces female to male transmission by up to 60 percent.
  • Mother to child transmission: Without intervention, the risk of vertical transmission is 15 to 45 percent. With effective ART during pregnancy, delivery, and breastfeeding, the risk falls below 5 percent. Elimination of mother to child transmission is achievable and has been validated in several countries.
  • Comorbidities and coinfections: Tuberculosis is the leading cause of death among people with HIV. Hepatitis B and C co infections are common. HIV related comorbidities such as cardiovascular disease, diabetes, and neurocognitive disorders require integrated care models that address multiple chronic conditions simultaneously.
  • Key populations: Men who have sex with men, sex workers, people who inject drugs, transgender individuals, and prisoners account for a disproportionate share of new infections. Tailored approaches that address legal barriers and social marginalization are essential for reaching these groups and achieving equity in HIV outcomes.
Scope of Practice

Role: HIV Program Manager

Within scope:
  • Coordinating HIV testing campaigns and linkage-to-care programs
  • Monitoring program performance against UNAIDS targets
  • Training healthcare workers on current guidelines
  • Managing supply chain for ART and diagnostic test kits
Outside scope:
  • Prescribing antiretroviral medications
  • Conducting clinical diagnosis of HIV or AIDS
  • Performing laboratory tests or interpreting viral loads
  • Making individual treatment decisions
Quick Revision
  • HIV emerged in the 1980s and has become a global pandemic with 38 million people living with the virus.
  • ART has transformed HIV into a manageable chronic condition; viral suppression eliminates transmission risk.
  • UNAIDS 95-95-95 targets guide global efforts to end AIDS by 2030.
  • Stigma, funding, and health system capacity remain critical challenges.

Like what you see? Unlock the full course to continue.

Limited Offer
$9.99
Limited Offer $9.99